CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
OPERATING ACTIVITIES:
Net income	$ 3,748	$ 45,537	$ 11,346
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	28,519	18,847	19,070
Amortization, including accretion of debt discount	6,802	1,113	1,129
Deferred income taxes	(2,733)	23,938	(469)
Earnings of equity method investees, less dividends received	(760)	(10,034)	(4,889)
Gain on sale of fixed assets	(268)	(88)	(42)
Share-based compensation expense	4,890	4,423	2,661
Excess tax benefits from share-based payments	0	0	(395)
Asset impairments	0	807	0
Goodwill impairment charge	0	4,945	0
Loss on early extinguishment of debt	0	0	1,346
Gain on previously held equity interest	0	(65,372)	0
Changes in operating assets and liabilities -
Accounts receivable, net	19,466	(11,658)	(21,012)
Inventories, net	20,995	(9,895)	(12,307)
Prepaid expenses and other	1,772	(4,783)	(1,624)
Accounts payable	(7,282)	(23,879)	16,705
Accrued expenses and other	396	27,020	2,332
Net cash provided by operating activities	75,545	921	13,851
INVESTING ACTIVITIES:
Capital expenditures	(26,352)	(26,290)	(18,574)
Proceeds from sale of fixed assets	521	3,863	56
Capital contribution from noncontrolling interest	0	397	0
Business acquisitions, net of cash acquired	(19,779)	(7,753)	0
Net cash used for investing activities	(45,610)	(29,783)	(18,518)
FINANCING ACTIVITIES:
Extinguishment of senior notes	0	0	(183,000)
Proceeds from issuance of senior secured notes	0	0	170,625
Proceeds from issuance of other debt	22,146	1,408	690
Repayments of other debt	(48,327)	(968)	(278)
Revolving credit facility borrowings	21,579	38,993	8,389
Revolving credit facility payments	(59,600)	(554)	(8,335)
Other financing costs	0	(605)	(1,365)
Repurchase of shares to satisfy employee tax withholding	(1,273)	(752)	(826)
Excess tax benefits from share-based payments	0	0	395
Premiums related to early extinguishment of debt	0	0	(324)
Net cash provided by (used for) financing activities	(65,475)	37,522	(14,029)
Effect of exchange rate changes on cash and cash equivalents	1,364	(1,903)	(1,237)
Net change in cash and cash equivalents	(34,176)	6,757	(19,933)
Cash and cash equivalents at beginning of period	78,731	71,974	91,907
Cash and cash equivalents at end of period	44,555	78,731	71,974
Supplemental disclosure of cash flow information:
Cash paid for interest	20,317	17,494	20,755
Cash paid for income taxes, net	4,345	1,365	1,213
Supplemental disclosure of non cash financing activities:
Change in fair value of interest rate swap	1,134	4,095	(3,017)
Issuance of Common Shares for acquisition of additional PST interest	$ 10,197	$ 5,113	$ 0

The aggregate expense charged against earnings to allocate the cost of intangible assets including deferred financing costs (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Also included in this amount is the accretion of the debt discount and the deferred financing costs which are a component of interest expense representing the periodic charge against earnings to reflect amortization of debt discounts and deferred financing costs over the life of the related debt instrument. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.

No definition available.